Miller Victoria A, Baker Justin N, Leek Angela C, Drotar Dennis, Kodish Eric
*Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA †Division of Quality of Life and Palliative Care, St. Jude Children's Research Hospital, Memphis, TN ‡Department of Bioethics ∥Center for Ethics, Humanities and Spiritual Care, Cleveland Clinic, Cleveland §Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
J Pediatr Hematol Oncol. 2014 Nov;36(8):635-40. doi: 10.1097/MPH.0000000000000112.
To examine children's and adolescents' involvement in the informed consent conference for phase I cancer trials and test associations with patient age, ease of understanding, and pressure to participate.
Participants included 61 patients aged 7 through 21 years who were offered participation in a phase I trial. Consent conferences were audiotaped, transcribed, and coded for communication between patients and physicians and between patients and parents.
On the basis of word counts, the mean proportion of the consent conference in which the physician was talking to the patient was 36%; the vast majority (73%) of this communication consisted of giving information. Physician-patient communication increased with age, but overall levels of patient-to-physician communication were low (3%). After controlling for patient age, greater physician-to-patient communication was associated with greater ease of understanding.
The focus on providing information in the context of informed consent may come at the expense of other communication exchanges that are important to patients, especially in the context of end-of-life decisions. Children and adolescents may benefit from the assent process when physicians direct more of their communication to them. Future research should identify the reasons for low patient communication during the consent conference and strategies to enhance their participation in decision making about phase I trial enrollment.
研究儿童和青少年参与癌症I期试验知情同意会议的情况,并检验其与患者年龄、理解难易程度以及参与压力之间的关联。
参与者包括61名年龄在7至21岁之间、被邀请参与I期试验的患者。对知情同意会议进行录音、转录,并对患者与医生之间以及患者与家长之间的交流进行编码。
根据单词计数,医生与患者交谈的知情同意会议平均比例为36%;这种交流的绝大多数(73%)是提供信息。医患交流随年龄增长而增加,但患者与医生交流的总体水平较低(3%)。在控制患者年龄后,更多的医患交流与更高的理解难易程度相关。
在知情同意的背景下专注于提供信息,可能会以牺牲对患者重要的其他交流为代价,尤其是在临终决策的背景下。当医生将更多交流指向儿童和青少年时,他们可能会从同意过程中受益。未来的研究应确定知情同意会议期间患者交流较少的原因,以及提高他们参与I期试验入组决策的策略。